Molecule Information
General Information of the Molecule (ID: Mol04109)
| Name |
Forkhead box M1 (FOXM1)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
Forkhead-related protein FKHL16; Hepatocyte nuclear factor 3 forkhead homolog 11; M-phase phosphoprotein 2; MPM-2 reactive phosphoprotein 2; Transcription factor Trident; Winged-helix factor from INS-1 cells
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
FOXM1
|
||||
| Gene ID | |||||
| Location |
chr12:2857680-2877174[-]
|
||||
| Sequence |
MKTSPRRPLILKRRRLPLPVQNAPSETSEEEPKRSPAQQESNQAEASKEVAESNSCKFPA
GIKIINHPTMPNTQVVAIPNNANIHSIITALTAKGKESGSSGPNKFILISCGGAPTQPPG LRPQTQTSYDAKRTEVTLETLGPKPAARDVNLPRPPGALCEQKRETCADGEAAGCTINNS LSNIQWLRKMSSDGLGSRSIKQEMEEKENCHLEQRQVKVEEPSRPSASWQNSVSERPPYS YMAMIQFAINSTERKRMTLKDIYTWIEDHFPYFKHIAKPGWKNSIRHNLSLHDMFVRETS ANGKVSFWTIHPSANRYLTLDQVFKPLDPGSPQLPEHLESQQKRPNPELRRNMTIKTELP LGARRKMKPLLPRVSSYLVPIQFPVNQSLVLQPSVKVPLPLAASLMSSELARHSKRVRIA PKVLLAEEGIAPLSSAGPGKEEKLLFGEGFSPLLPVQTIKEEEIQPGEEMPHLARPIKVE SPPLEEWPSPAPSFKEESSHSWEDSSQSPTPRPKKSYSGLRSPTRCVSEMLVIQHRERRE RSRSRRKQHLLPPCVDEPELLFSEGPSTSRWAAELPFPADSSDPASQLSYSQEVGGPFKT PIKETLPISSTPSKSVLPRTPESWRLTPPAKVGGLDFSPVQTSQGASDPLPDPLGLMDLS TTPLQSAPPLESPQRLLSSEPLDLISVPFGNSSPSDIDVPKPGSPEPQVSGLAANRSLTE GLVLDTMNDSLSKILLDISFPGLDEDPLGPDNINWSQFIPELQ Click to Show/Hide
|
||||
| 3D-structure |
|
||||
| Function |
Transcription factor regulating the expression of cell cycle genes essential for DNA replication and mitosis (PubMed:19160488, PubMed:20360045). Plays a role in the control of cell proliferation (PubMed:19160488). Also plays a role in DNA break repair, participating in the DNA damage checkpoint response (PubMed:17101782). Promotes transcription of PHB2 (PubMed:33754036). .
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Neuroblastoma [ICD-11: 2AOO.11] | [1] | |||
| Metabolic Type | Lipid metabolism | |||
| Resistant Disease | Neuroblastoma [ICD-11: 2AOO.11] | |||
| Resistant Drug | Simvastatin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | Terpenoid backbone biosynthesis | Activation | hsa00900 | |
| In Vivo Model | NOD/SCID mice, with fresh tissue from patient | Mice | ||
| Experiment for Molecule Alteration |
qRT-PCR | |||
| Experiment for Drug Resistance |
Tumor volume assay | |||
| Mechanism Description | Like dipyridamole (41, 57), caffeine can block statin-induced feedback activation of SREBP2 and mevalonate pathway enzymes. Our data suggest that this action of caffeine depends on its activity as an antagonist of adenosine receptors (43, 59, 62), as evidenced by the findings that supplemental adenosine can abrogate the ability of caffeine to block statin-induced feedback activation SREBP2 and mevalonate pathway enzymes and to enhance the antigrowth effect of simvastatin. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
